Epic Systems holds the medical records of 250 million patients. That is not a number to be read casually. It represents 36% of the acute-care hospital market in the United States. On March 2025, OpenAI announced that ChatGPT Health would be integrated into Epic's ecosystem via read-only access. The market applauded. The analysts applauded. The engineers did not.
Read-only access is a contract term, not a security guarantee. The ledger does not lie, only the operators do. And in this case, the operator is OpenAI—a company whose entire business model depends on ingesting and learning from data. The integration is framed as a conservative entry into healthcare, a minimal-risk pilot. That framing is false. The risk is not in the write path. The risk is in the read path, in what happens to the data after it is read, and in the absence of an audit trail that anyone outside a closed room can verify.
I have spent 18 years auditing systems where trust is a liability and verification is an asset. I audited the Ethereum Merge transition logic and found edge cases that could have destabilized the chain. I dissected FTX's balance sheet and found a $7.2 billion discrepancy between on-chain transactions and public reserve proofs. I know what it means when a system says 'trust me.' This integration says 'trust us' with a HIPAA BAA attached. That is not enough.
Let me establish the context. Epic Systems is the dominant electronic health record provider in the United States. Its clients include Mayo Clinic, Cleveland Clinic, Johns Hopkins—institutions that command the highest trust in American medicine. Epic's backend is built on MUMPS and Cache, a decades-old stack that prioritizes stability over modern interfaces. The standard API layer is HL7 FHIR, which allows structured access to patient demographics, observations, medication requests. OpenAI's integration rides on this FHIR API. The model reads patient data, answers clinical questions, assists with documentation, and generates patient education materials. It cannot write to the EHR. That is the design.
But read-only is not safe. Consider the data flow. The model receives a context window—say, 200,000 tokens. A patient with a complex oncology history has an EHR that may contain millions of tokens. The integration must therefore include a pre-retrieval step: a subsystem that selects which portions of the EHR are relevant to the current query. That subsystem is likely a rule-based engine or a smaller ML model. No one outside OpenAI knows its logic. That is a black box inside a larger black box. From an audit perspective, this is equivalent to a smart contract that calls an external oracle without verifying the oracle's data. I have seen such patterns fail. They fail silently.
The hidden architecture is the first of many issues. The article that triggered my analysis mentioned a 'context window strategy' but did not specify it. Based on my experience integrating LLMs into high-stakes environments, I can infer that the selection layer must filter. But what filters, and under what governance? The principle of least privilege is not just about read-only access. It is about field-level controls, time-of-access constraints, and purpose limitations. Does the model see a patient's psychiatric history when querying for a broken leg? Does it see HIV status when answering a dermatology question? The answer depends on configuration at each hospital site. And configurations are human decisions. Humans make errors. That is why we have audit trails. But an audit trail that logs 'model accessed 200 tokens for patient X' is useless. It must log which fields were read, which retrieval algorithm was used, and what the model's output was. Did OpenAI disclose this? No.
Then there is the de-identification question. HIPAA allows de-identified data to be used without patient consent. Does ChatGPT Health receive fully identified protected health information or a de-identified subset? The source article offered no evidence. My industry experience suggests that most healthcare AI integrations use identified data because clinical utility is higher. That means the model is processing real patient names, dates of birth, social security numbers—either in prompts or in training data. If the model is fine-tuned on such data—and OpenAI has every incentive to fine-tune—then the model weights themselves become a liability. A model trained on patient data can, in theory, be prompted to output memorized information. This is called memorization, and it has been demonstrated in medical LLMs. The reading is not passive. It is an extraction.
The commercial analysis adds another layer of deception. The integration is touted as a 'strategic entry' into the high-value healthcare market. But the raw numbers reveal a slower play. OpenAI's annualized revenue is estimated at $100 billion in 2025—I have seen estimates, but they are not audited—and healthcare represents less than five percent of that. The integration with Epic is a land-grab for data, not revenue. The real value lies in what OpenAI learns from the interactions: how doctors query, what questions are asked, which results are ignored. This is a data flywheel that competitors cannot replicate. Microsoft's Nuance DAX, which was acquired for $19.7 billion, already had deep Epic integration and a head start in clinical documentation. Google's Med-PaLM 2 achieved 86.5% on MedQA, outperforming GPT-4o. But OpenAI has something those giants lack: a direct contract with the EHR gatekeeper. That contract, likely worth tens of millions annually in licensing fees, purchases access to the most sensitive data in America.
Let us talk about liability. The source article asked: if a doctor makes a wrong decision based on AI output, who is responsible? That is the wrong question. The correct question is: who can prove what happened? In a blockchain system, every query would be recorded on an immutable ledger. In this integration, the queries are logged in OpenAI's cloud and Epic's servers. But the logs are not public. The model's reasoning is not recorded. The selection layer's decisions are not recorded. If a patient is harmed, the plaintiff's attorney will subpoena the logs. The logs may show that the model output a suggestion for a contraindicated drug. But the model is a deterministic function of its weights and the input. There is no human logic to interrogate. The AI does not negotiate; it only confirms. It confirms what the training data predicted. And if the training data contains systemic biases—which it does—those biases are amplified across 2,500 hospitals.
The competitive teardown reveals something else. OpenAI's capabilities in text reasoning, code, math, and agent integration are top-tier. In medical domains, however, they lag. The source article rated OpenAI's medical capability as 3/5, behind Med-PaLM 2. That is a known issue. Why would Epic partner with a model that is less accurate in medicine than Google's? Because accuracy is not the sole criterion. Workflow integration, change management, and contractual indemnities matter more. Epic is a private company. Its founder, Judy Faulkner, controls it with an iron grip. Epic has been resistant to AI for years, but external pressure from Microsoft's partnership with Cerner (now Oracle) and the rise of ambient documentation tools forced its hand. The partnership with OpenAI is Epic's way of placating its hospital clients without building an AI team internally. It is a defensive move, not a visionary one.
There is also the issue of standard-setting. By integrating with Epic, OpenAI gains a seat at the table for defining how AI agents access health data. This is the 'standards trap' that we saw in the early days of enterprise software. The company that controls the API format controls the market. OpenAI is already the default API for many developers. Now it becomes the default no-code AI layer for hospitals. The moat deepens. But moats can become prisons. The hospital customers are locked into OpenAI's pricing and policy whims. There is no escape clause that allows them to take their fine-tuned models elsewhere. The data they pour into the system becomes the property of the platform—indirectly, via retained logs and training data.
Now, let me give the contrarian view. The bulls will say that read-only access is the correct first step. It minimizes immediate harm. It allows clinicians to evaluate AI output without the risk of automated orders being written to the EHR. It respects medical workflows. And they are right. The integration does not replace a doctor's judgment; it augments it. The typical use cases—quick chart review, patient education material generation, medication interaction queries—are low-risk. The model cannot prescribe or change orders. That is a genuine safety feature. Furthermore, the conservative approach may be a deliberate strategy to avoid FDA scrutiny. If the tool is presented not as a medical device but as a clinical decision support, it may escape 510(k) clearance. That is a regulatory arbitrage. It is also a temporary advantage. The FDA is watching.
The contrarian view also notes that this integration is the first step toward a more open healthcare data standard. If OpenAI's FHIR-based approach proves successful, it may pressure other EHR vendors to adopt similar APIs. That could lower interoperability barriers. A more interoperable healthcare system is a healthier healthcare system. The 'read-only' philosophy is a gateway to safer, more accountable AI. But that optimism ignores the fundamental power imbalance. The patient has no recourse. The hospital signed the contract. The doctor uses the tool. The patient is the dataset.
The core insight that the source article missed is this: the integration is not about AI in medicine. It is about control over the medical data supply chain. Epic controls the source. OpenAI controls the inference. Microsoft controls the compute via Azure. The patient controls nothing. This is the antithesis of the user-centric data sovereignty that blockchain advocates have championed for a decade. We built decentralized ledgers to prevent exactly this kind of centralized accumulation of sensitive information. Yet here we are, voluntarily handing over the most intimate details of human life to a model trained on an unknown corpus with an unverified lineage.
Proof is cheaper than trust, yet still ignored. In blockchain, we have a primitive called a Merkle tree. It allows you to prove that a specific piece of data was included in a block without revealing the entire block. The OpenAI integration has no equivalent. There is no cryptographic proof that the selection layer did not leak a patient's mental health record to an unrelated query. There is no proof that the model's output was generated from the specific context provided rather than from a hidden bias. There is no proof that the model's weights—the learned parameters—do not contain encoded fragments of patient data. The only proof is the BAA, a legal document that provides a remedy after harm, not a prevention of harm.
I have seen this pattern before. In the FTX collapse, the balance sheet discrepancy was hidden in plain sight. The terms of service allowed for the commingling of funds. The auditors did not look beyond the legal language. In the Ethereum Merge, the difficulty bomb schedule had edge cases that would not surface until minutes before the chain stalled. The developers did not test for them. In this integration, the risk is not in the code; it is in the governance. Who decides what data is relevant for a query? That is not a technical decision. It is a policy decision. And policy decisions are made by humans who are fallible.
The source article raised the question of patient informed consent. It said the legal and ethical gray zone is 'completely unaddressed.' That is correct. There is no evidence that patients are being told their data may be processed by OpenAI's models. There is no opt-out mechanism. The Health Insurance Portability and Accountability Act permits covered entities to share PHI with business associates without patient consent for treatment, payment, and operations. But is training a model 'operations'? The Office for Civil Rights has not clarified this. Until they do, every hospital that activates ChatGPT Health is engaged in a unilateral reinterpretation of consent. That is a contract violation waiting for litigation.
Let me quantify the infrastructure. If 200 hospitals adopt the tool, each with 500 physicians, each making 20 queries per day, the daily token volume is four billion. At 2,000 tokens per query, that is about 2,300 QPS at peak. This is not a significant load for OpenAI's fleet—they have hundreds of thousands of GPUs. But the latency requirement is two seconds. That demands low-level optimization, possibly model distillation or quantization. Those optimizations alter the model's behavior. They are not validated. A quantized model that achieves 99.9% accuracy on the general benchmark may have a 0.1% error rate on rare clinical cases. In medicine, that is the difference between life and death. The source article called this a 'medium' inference load. I call it a liability multiplier.
There is a deeper, more disturbing issue. The integration is read-only today. But contracts are living documents. The BAA can be amended. The API permissions can be expanded. The read-only restriction is a policy choice, not a technical constraint. A future 'update' could add write access for care coordination, and then for automated orders. The precedent set by the initial integration—hospitals surrendering their data governance to a private AI company—paves the way for complete automation. The only audit trail is the one that exists in the moment. History is the only reliable audit trail. And history says that every centralized data repository eventually gets exploited.
The 'cold dissector' view demands prescriptive governance. I propose three requirements for any AI-EHR integration. First, full transparency: the selection layer's logic must be published or audited by an independent third party. Second, patient consent: no data should be processed for training without explicit, granular consent. Third, liability assignment: the hospital and the vendor must agree on a clear indemnification clause that does not shift blame to the physician. These are not radical demands. They are standard risk management practices for any high-stakes system. Yet they are absent from this announcement.
History, after all, is the only reliable audit trail. And history will record that in 2025, OpenAI and Epic Systems taught the world that the most sensitive data on earth was handed to a model with no readouts, no verifiable logs, and no accountability. That is a mistake we cannot afford to repeat. The ledger does not lie, only the operators do. In healthcare, the ledger is the patient's body. And it has been read, disseminated, and stored in a place where no subpoena can reach it: the weights of a neural network.
The takeaway is not doom. It is an invitation. The blockchain community has spent years building verifiable, transparent, and user-controlled data systems. That work now has a new relevance. If healthcare AI is to be trusted, it must be built on a foundation of cryptographic proof, not contractual promise. The next five years will determine whether the future of medicine is a black box or a glass box. The choice is not technical. It is ethical.

